Comparison of Early Postnatal Clinical Outcomes of Newborns Born to Pregnant Women With COVID-19: A Case-control Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Covid19
- Sponsor
- Kahramanmaras Sutcu Imam University
- Enrollment
- 202
- Locations
- 1
- Primary Endpoint
- Vertical transmission
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
A case-control trial was conducted to test the early postpartum period clinical outcomes of newborns born to pregnant women with and without COVID-19.
Investigators
Deniz Akyıldız
Assistant professor
Kahramanmaras Sutcu Imam University
Eligibility Criteria
Inclusion Criteria
- •Pregnant women on labor or preterm labor. Pregnant women who underwent programmed or emergence cesarean
Exclusion Criteria
- •Those who were transferred to another hospital without or within a short period of delivery
Outcomes
Primary Outcomes
Vertical transmission
Time Frame: 48 hours after birth
Determine the prevalence of COVID-19 in newborns born to pregnant women with COVID-19 with PCR from a nasopharyngeal swab.
Neonatal birth outcomes
Time Frame: At birth
Determine the neonatal outcomes of the newborn specifying the birth week of the newborn, delivery type (vaginal or cesarean), birth weight (g), APGAR scores in the first and fifth minutes after birth.
Neonatal postnatal outcomes
Time Frame: Within 48 hours after birth
Determine the prevalence of neonatal postnatal outcomes of the newborn specifying the respiratory system illness, intensive care need, oxygen need, neonatal mortality, general health status, and breastfeeding status.